Isolation and functional characterization of the A32 melanoma-associated antigen - PubMed (original) (raw)
. 1994 May 1;54(9):2514-20.
Affiliations
- PMID: 8162602
Isolation and functional characterization of the A32 melanoma-associated antigen
I M Shih et al. Cancer Res. 1994.
Abstract
Cell surface melanoma-associated antigens can mediate cell-cell or cell-substrate adhesion, signal transduction, proteolysis, or immune recognition and play a key role in determining invasive and metastatic competence of the tumor cells. The melanoma-associated antigen, A32, was defined by a murine monoclonal antibody and was immunoprecipitated as a single 113 kDa integral membrane glycoprotein containing sialic acid and HNK-1 carbohydrate moieties. Immunohistochemistry revealed the presence of A32 antigen on most melanomas and nevi but not on normal epidermal melanocytes. Of the normal tissues tested, only endothelium, smooth muscle, cerebellum, and hair follicles expressed the A32 antigen. Tryptic peptides of the A32 antigen obtained after immunoaffinity chromatography showed sequence identity to MUC18 antigen, a member of the immunoglobulin supergene family. Melanoma cells adhered to affinity-purified A32 antigen immobilized to a solid phase, and the adhesion was blocked by either soluble A32 antigen or monoclonal antibody against the HNK-1 carbohydrate moiety. These findings, together with the observation that A32 antigen is concentrated in cell-cell contact borders, suggest that this antigen is an adhesion molecule with a possible role in tumor invasion and metastasis.
Similar articles
- A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H, Baril P, Tabone E, Bérard F, Sanhadji K, Balme B, Wolf F, Perrot H, Thomas L. Boukerche H, et al. Cancer Res. 2000 Oct 15;60(20):5848-56. Cancer Res. 2000. PMID: 11059782 - Fluctuations in the expression of a glycolipid antigen associated with differentiation of melanoma cells monitored by a monoclonal antibody, Leo Mel 3.
Werkmeister JA, Triglia T, Mackay IR, Dowling JP, Varigos GA, Morstyn G, Burns GF. Werkmeister JA, et al. Cancer Res. 1987 Jan 1;47(1):225-30. Cancer Res. 1987. PMID: 3791209 - Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
Kiniwa Y, Fujita T, Akada M, Ito K, Shofuda T, Suzuki Y, Yamamoto A, Saida T, Kawakami Y. Kiniwa Y, et al. Cancer Res. 2001 Nov 1;61(21):7900-7. Cancer Res. 2001. PMID: 11691810 - The role of CD146 (Mel-CAM) in biology and pathology.
Shih IM. Shih IM. J Pathol. 1999 Sep;189(1):4-11. doi: 10.1002/(SICI)1096-9896(199909)189:1<4::AID-PATH332>3.0.CO;2-P. J Pathol. 1999. PMID: 10451481 Review. - The progression associated antigen MUC18: a unique member of the immunoglobulin supergene family.
Johnson JP, Rothbächer U, Sers C. Johnson JP, et al. Melanoma Res. 1993 Oct;3(5):337-40. doi: 10.1097/00008390-199310000-00006. Melanoma Res. 1993. PMID: 8292890 Review.
Cited by
- A Cell Surface-Binding Antibody Atlas Nominates a MUC18-Directed Antibody-Drug Conjugate for Targeting Melanoma.
Shi J, Jiao T, Guo Q, Weng W, Ma L, Zhang Q, Wang L, Zhang J, Chen C, Huang Y, Wang M, Pan R, Tang Y, Hu W, Meng T, Liu SH, Guo J, Kong Y, Meng X. Shi J, et al. Cancer Res. 2023 Nov 15;83(22):3783-3795. doi: 10.1158/0008-5472.CAN-23-1356. Cancer Res. 2023. PMID: 37668527 Free PMC article. - METCAM Is a Potential Biomarker for Predicting the Malignant Propensity of and as a Therapeutic Target for Prostate Cancer.
Wu JC, Wu GJ. Wu JC, et al. Biomedicines. 2023 Jan 13;11(1):205. doi: 10.3390/biomedicines11010205. Biomedicines. 2023. PMID: 36672713 Free PMC article. Review. - Galectin-3 Is a Natural Binding Ligand of MCAM (CD146, MUC18) in Melanoma Cells and Their Interaction Promotes Melanoma Progression.
Pang Y, Maxwell E, Sindrewicz-Goral P, Shapanis A, Li S, Morgan M, Yu LG. Pang Y, et al. Biomolecules. 2022 Oct 10;12(10):1451. doi: 10.3390/biom12101451. Biomolecules. 2022. PMID: 36291660 Free PMC article. - Wnt5a signaling induced phosphorylation increases APT1 activity and promotes melanoma metastatic behavior.
Sadeghi RS, Kulej K, Kathayat RS, Garcia BA, Dickinson BC, Brady DC, Witze ES. Sadeghi RS, et al. Elife. 2018 Apr 12;7:e34362. doi: 10.7554/eLife.34362. Elife. 2018. PMID: 29648538 Free PMC article. - CD146, a novel target of CD44-signaling, suppresses breast tumor cell invasion.
Ouhtit A, Abdraboh ME, Hollenbach AD, Zayed H, Raj MHG. Ouhtit A, et al. Cell Commun Signal. 2017 Nov 9;15(1):45. doi: 10.1186/s12964-017-0200-3. Cell Commun Signal. 2017. PMID: 29121955 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases